June 18, 2007 - Brain specialists associated with the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital say the ability to incorporate, in real time, two high-tech imaging tools into the operating room can improve the functional abilities of patients who undergo brain surgery.

June 18, 2007 – Aurora Imaging Technology, Inc., today announced the establishment of Aurora Asia, a wholly-owned subsidiary, which will market the Aurora 1.5 Tesla Dedicated Breast MRI System in Asia as the company responds to the growing need for advanced breast imaging among Asian women.

June 18, 2007 - Researchers at the University of Pennsylvania have created the first three-dimensional optical images of human breast cancer in patients based on tissue fluorescence which relies on the presence of fluorophore molecules in tissue that re-radiate fluorescent light after illumination by excitation light of a different color.

June 18, 2007 – IBA Molecular has begun delivery of Iodine-124 to PET Centers is Europe. The positron emitter has been on the market in North America since 2004.

According to the company, because of its properties and convenient half-life of 100.3 hours, I-124 is ideal for radiolabeling antibodies and has sparked a growing interest in the medical oncology community in Europe.

The Vreije Universiteit in Amsterdam will serve as I-124’s primary production location in Europe.

For more information: www.iba-worldwide.com

June 18, 2007 - Siemens Medical Solutions Ultrasound Division is showcasing its comprehensive cardiovascular risk assessment solutions on its ACUSON X300 ultrasound platform at the 18th Annual Scientific Sessions of the American Society of Echocardiography (ASE), in Seattle, with the purpose of testing patients’ vascular age.
The company’s syngo Arterial Health Package (AHP) for cardiovascular risk assessment provides semi-automated quantification tools for users that help to assess the cardiovascular risk potential of patients using the concept of “vascular age.”

June 15, 2007 — According to a Yale School of Medicine Study, when medical residents work shorter hours, fewer patients are transferred to intensive care and there are not as many interventions by pharmacists to avoid errors in medication.

In addition, when residents' work schedules are limited to 80 hours per week more patients are discharged to their homes or rehabilitation centers instead of facilities such as nursing homes, the researchers found.

June 15, 2007 — Conductive Compounds Inc. (CCI), a worldwide provider of conductive and resistive inks, coatings and adhesives, today announced two silver chloride (AgCl) inks for medical diagnostic sensor applications.

The conductive inks are specifically designed for use on defibrillator pads, as well as disposable EEG and EKG sensors. The two products, AGCL-510 and AGCL-675C, are optimized for gravure/flexographic and screen printing and can also be used in pad printing.

June 15, 2007 — Officials at Luna Innovations recently announced an agreement with Intuitive Surgical Inc., the world's only maker of surgical robots.

Luna is tapping into a trend known as minimally invasive surgery, in which doctors use tiny instruments inserted through small incisions in a patient.

In more than 90 percent of cases, the procedure is done manually, and the surgeon manipulates the instruments with the aid of a tiny camera inserted into the patient.

June 15, 2007 - Baxa Corporation recently announced the expansion of its Valimed System, which uses enhanced photoemission spectroscopy to quickly validate high-risk medication admixtures, as well as returned narcotics to provide an increased level of patient safety.

ValiMed compares a medication's spectroscopic signature to the Medication Signature Library and returns an easy-to-understand "validated" or "not validated" result, requiring no user interpretation.

June 15, 2007 – The nonprofit Caring for Carcinoid Foundation announced it is moving forward on the National Cancer Institute (NCI) Carcinoid Summit now confirmed for Sept. 24-25 in Washington, D.C.

As the world’s largest funder of cancer research, NCI is the nation’s principal governmental cancer research agency with a budget of more than $5 billion.

The goal of the CFCF’s 2007 Research Action Plan is the facilitation of the Summit as part of its quest to revolutionize carcinoid/NET research and rapidly discover a cure.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now